Market Tracker

03/31 12:52pm ET

Xenoport Inc (NASDAQ:XNPT)

7.27
Delayed Data
As of 12:36pm ET
 +0.005 / +0.07%
Today’s Change
3.15
Today|||52-Week Range
9.60
-17.16%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close7.26
Today’s open7.18
Day’s range7.16 - 7.34
Volume457,826
Average volume (3 months)714,302
Market cap$455.6M
Dividend yield--
Data as of 12:36pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+55.25%
Earnings growth (this year)-51.19%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+489.46%
P/E ratioNM
Price/Sales11.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.13-1.74%
SCLNSciClone Pharmaceuti...-0.10-1.12%
IGIGI Laboratories Inc-0.25-2.96%
RVNCRevance Therapeutics...+1.05+5.35%
Data as of 12:49pm ET, 03/31/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$46.9M
Annual profit (last year)-$49.3M
Net profit margin-105.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald W. Barrett
Chief Operating Officer &
Executive Vice President
Vincent J. Angotti
Corporate headquarters
Santa Clara, California

Forecasts